Australia markets open in 6 hours 1 minute

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.78-0.15 (-1.26%)
As of 01:57PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-131,736
-133,816
-121,755
-78,996
-36,168
-
Depreciation & amortisation
2,583
2,371
2,973
3,334
3,644
-
Deferred income taxes
-
0
0
345
10,608
-
Stock-based compensation
27,374
28,216
26,969
20,991
19,575
-
Change in working capital
248
8,024
6,789
-13,688
12,900
-
Accounts receivable
10,039
11,704
3,258
-84
27,821
-
Accounts payable
-6,853
-1,151
-4,634
3,774
-883
-
Other working capital
-113,293
-112,212
-86,907
-70,746
5,643
-
Other non-cash items
-4,719
-5,243
-929
-4,098
-3,775
-
Net cash provided by operating activities
-107,319
-103,154
-84,782
-69,996
7,088
-
Cash flows from investing activities
Investments in property, plant and equipment
-5,974
-9,058
-2,125
-750
-1,445
-
Purchases of investments
-494,898
-373,391
-171,446
-307,348
-338,553
-
Sales/maturities of investments
412,467
328,871
228,468
345,089
359,828
-
Net cash used for investing activities
-88,405
-53,578
54,897
36,991
19,830
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-86
Other financing activities
185,837
195,918
-1,229
-534
-1,498
-
Net cash used provided by (used for) financing activities
186,088
198,126
20,033
3,080
8,983
-
Net change in cash
-9,636
41,394
-9,852
-29,925
35,901
-
Cash at beginning of period
77,146
47,962
57,814
87,739
51,838
-
Cash at end of period
67,510
89,356
47,962
57,814
87,739
-
Free cash flow
Operating cash flow
-107,319
-103,154
-84,782
-69,996
7,088
-
Capital expenditure
-5,974
-9,058
-2,125
-750
-1,445
-
Free cash flow
-113,293
-112,212
-86,907
-70,746
5,643
-